MD-39-AM
Product Specifications
UNSPSC Description
MD-39-AM exhibits antihypertensive, diuretic and saliuretic activities with good in vivo pharmacokinetic characters[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/md-39-am.html
Solubility
10 mM in DMSO
Smiles
CSC1=NC(NC2=CC=CC=C2)=C(C=CC=N3)C3=N1
Molecular Weight
268.34
References & Citations
[1]Monge A, et al., Diuretic and hypotensive activities of 4-anilino derivatives of 2-methylthiopyrido [2, 3-d] pyrimidines[J]. Arzneimittel-forschung, 1990, 40(11): 1230-1233.|[2]Pérez MJ, et al., Preliminary pharmacokinetics of a new pyridopyrimidine derivative. Arzneimittelforschung. 1991 Jun;41(6):640-4.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-19367/MD-39-AM-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-19367/
Clinical Information
No Development Reported
CAS Number
72564-74-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1006479-01 0.02 mg (E-Coli)
Recombinant Branchiostoma lanceolatum Actin, cytoplasmic
Ask
View Details MBS1006479-02 0.02 mg (Yeast)
Recombinant Branchiostoma lanceolatum Actin, cytoplasmic
Ask
View Details 
MBS1006479-03 0.1 mg (E-Coli)
Recombinant Branchiostoma lanceolatum Actin, cytoplasmic
Ask
View Details MBS1006479-04 0.1 mg (Yeast)
Recombinant Branchiostoma lanceolatum Actin, cytoplasmic
Ask
View Details